Literature DB >> 24050896

A relevant experimental model for human bronchiolitis obliterans syndrome.

Srebrena Atanasova1, Markus Hirschburger, Danny Jonigk, Martin Obert, Kathrin Petri, Alena Evers, Andreas Hecker, Jessica Schmitz, Andreas Kaufmann, Jochen Wilhelm, Trinad Chakraborty, Gregor Warnecke, Jens Gottlieb, Winfried Padberg, Veronika Grau.   

Abstract

BACKGROUND: The long-term success of human lung transplantation is limited by the development of bronchiolitis obliterans syndrome. Acute rejection episodes and infections are important risk factors and seem to play major pathogenic roles. We established a relevant experimental model that mimics important aspects of human bronchiolitis obliterans syndrome.
METHODS: The Fischer 344-to-Lewis rat strain combination was used for orthotopic left lung transplantation. Isogeneic transplantations were performed in the Lewis rat. Recipients were treated with ciclosporin for 10 days. Lipopolysaccharide or vehicle was instilled into the airways 28 days after transplantation. Grafts were monitored by computed tomography, and recipients were euthanized on Days 28-90. The messenger RNA expression of selected chemokines and their receptors was measured on Days 28, 29, 33, 40 after transplantation. Graft histopathology on Day 90 was compared with lungs from patients who underwent re-transplantation due to end-stage allograft dysfunction.
RESULTS: Lung allografts treated with ciclosporin and vehicle only sporadically displayed tissue remodeling. In contrast, lipopolysaccharide treatment induced severe inflammation. In the long-term, severe vascular remodeling, lung fibrosis, and fibroproliferative remodeling of airways were found that closely resemble the histopathologic changes in grafts from human patients with bronchiolitis obliterans syndrome. Chronic damage was virtually absent from pulmonary isografts and native right lungs. Chemokine (C-C motif) ligand 5 and chemokine (C-X-C motif) ligand 9-11, and their receptors, were over-expressed in allografts.
CONCLUSIONS: Our experimental model mirrors key aspects of human bronchiolitis obliterans syndrome. It will be useful to elucidate its pathogenesis and to develop therapeutic approaches improving the long-term outcome of human lung transplantation.
© 2013 International Society for Heart and Lung Transplantation. All rights reserved.

Entities:  

Keywords:  chemokines; chronic allograft damage; cytokines; lipopolysaccharide; lung transplantation; pulmonary vascular remodeling

Mesh:

Substances:

Year:  2013        PMID: 24050896     DOI: 10.1016/j.healun.2013.07.016

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

1.  miR-199b-5p Regulates Immune-Mediated Allograft Rejection after Lung Transplantation Through the GSK3β and NF-κB Pathways.

Authors:  Linhai Zhu; Haichao Xu; Wang Lv; Zhehao He; Peng Ye; Yiqing Wang; Jian Hu
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 2.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

3.  Update on Chronic Lung Allograft Dysfunction.

Authors:  Jason M Gauthier; Ramsey R Hachem; Daniel Kreisel
Journal:  Curr Transplant Rep       Date:  2016-08-02

4.  What makes a good pediatric transplant lung: Insights from in vivo lung morphometry with hyperpolarized 3 He magnetic resonance imaging.

Authors:  Emily F Fishman; James D Quirk; Stuart C Sweet; Jason C Woods; David S Gierada; Mark S Conradi; Marilyn J Siegel; Dmitriy A Yablonskiy
Journal:  Pediatr Transplant       Date:  2017-01-24

5.  Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation.

Authors:  Danny Jonigk; Berenice Rath; Paul Borchert; Peter Braubach; Lavinia Maegel; Nicole Izykowski; Gregor Warnecke; Wiebke Sommer; Hans Kreipe; Robert Blach; Adrian Anklamm; Axel Haverich; Matthias Eder; Michael Stadler; Tobias Welte; Jens Gottlieb; Mark Kuehnel; Florian Laenger
Journal:  J Pathol Clin Res       Date:  2016-12-10

6.  The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans.

Authors:  Chong Zhang; Yuequn Niu; Li Yu; Wang Lv; Haichao Xu; Abudumailamu Abuduwufuer; Jinlin Cao; Jian Hu
Journal:  J Cardiothorac Surg       Date:  2017-12-20       Impact factor: 1.637

7.  LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.

Authors:  Zheng-Liang Tu; Zhen-Yu Zhou; Hai-Chao Xu; Jin-Lin Cao; Peng Ye; Lu-Ming Wang; Wang Lv; Jian Hu
Journal:  J Cardiothorac Surg       Date:  2017-05-25       Impact factor: 1.637

8.  The role of HIF-1α-VEGF pathway in bronchiolitis obliterans after lung transplantation.

Authors:  Haichao Xu; Abudumailamu Abuduwufuer; Wang Lv; Zhenyu Zhou; Yunhai Yang; Chong Zhang; Jian Hu
Journal:  J Cardiothorac Surg       Date:  2019-01-29       Impact factor: 1.637

9.  Chronic lung allograft pathology lesions in two rat strain combinations.

Authors:  Federica Pezzuto; Francesca Lunardi; Marta Vadori; Davide Zampieri; Federica Casiraghi; Nadia Azzollini; Stefania Edith Vuljan; Marco Mammana; Luca Vedovelli; Marco Schiavon; Dario Gregori; Emanuele Cozzi; Federico Rea; Fiorella Calabrese
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

Review 10.  The role of innate immunity in the long-term outcome of lung transplantation.

Authors:  Mitsuaki Kawashima; Stephen C Juvet
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.